What is the current opinion on G-CSF usage for AML patients during induction and consolidation phases of treatment?

Topics: Hematologic Malignancies • Pediatric Oncology • AML

It used to be a contraindication for G-CSF use for AML patients, but currently, several protocols include it to decrease neutropenic duration.

Answer from: at Academic Institution

I agree with you that the use of G-CSF for AML patients is still controversial. There are two reasons for using G-CSF for patients with AML. One is to sensitize, or “prime,” the leukemia by driving quiescent blasts into cell cycle and by mobilizing blasts out of their protective niches a...

Comments

at Case Western Reserve University
Thank you very much, Dr. @Michele S. Redell! It is...

Related Questions